NASDAQ:SILK Silk Road Medical - SILK Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. $39.13 +0.20 (+0.51%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$39.07▼$40.6450-Day Range$38.09▼$55.5752-Week Range$27.30▼$58.04Volume735,001 shsAverage Volume701,160 shsMarket Capitalization$1.50 billionP/E RatioN/ADividend YieldN/APrice Target$52.83 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Silk Road Medical MarketRank™ ForecastAnalyst RatingHold2.25 Rating ScoreUpside/Downside36.9% Upside$53.57 Price TargetShort InterestBearish6.06% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews Sentiment0.52Based on 7 Articles This WeekInsider TradingSelling Shares$12.46 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.51) to ($1.32) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.06 out of 5 starsMedical Sector560th out of 1,004 stocksSurgical & Medical Instruments Industry59th out of 104 stocks 3.2 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $53.57, Silk Road Medical has a forecasted upside of 36.9% from its current price of $39.13.Amount of Analyst CoverageSilk Road Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.06% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Silk Road Medical has recently increased by 4.02%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 2.0 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Silk Road Medical this week, compared to 2 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,459,868.00 in company stock.Percentage Held by InsidersOnly 7.66% of the stock of Silk Road Medical is held by insiders.Percentage Held by Institutions96.43% of the stock of Silk Road Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.51) to ($1.32) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -25.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -25.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 9.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Silk Road Medical (NASDAQ:SILK) StockSilk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.Read More Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SILK Stock News HeadlinesApril 1, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Receives New Coverage from Analysts at B. RileyApril 1, 2023 | msn.comB. Riley Securities Initiates Coverage of Silk Road Medical (SILK) with Buy RecommendationApril 1, 2023 | Investorplace Media (Ad)5 Stocks to Buy ImmediatelyAmerica’s #1 stock picker issues 5 buy alerts – one of which is positioned to be the next Tesla. Just click to claim your copy. March 31, 2023 | realmoney.thestreet.comSilk Road Medical Gets a Fundamental SupporterMarch 31, 2023 | finance.yahoo.comDoes Silk Road Medical Have a Smooth Path Forward?March 27, 2023 | finance.yahoo.comWhile Silk Road Medical (NASDAQ:SILK) shareholders have made 17% in 3 years, increasing losses might now be front of mind as stock sheds 8.4% this weekMarch 14, 2023 | benzinga.comSilk Road Medical Stock (NASDAQ:SILK), Guidance and ForecastMarch 11, 2023 | msn.comCitigroup Upgrades Silk Road Medical (SILK)April 1, 2023 | Investorplace Media (Ad)5 Stocks to Buy ImmediatelyAmerica’s #1 stock picker issues 5 buy alerts – one of which is positioned to be the next Tesla. Just click to claim your copy. March 10, 2023 | markets.businessinsider.comCitigroup upgrades Silk Road Medical (SILK) to a HoldMarch 7, 2023 | seekingalpha.comSilk Road Medical: Today Best Nearby Cap-Gain Medical Equipment Stock ProspectMarch 1, 2023 | finance.yahoo.comSilk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial OutlookMarch 1, 2023 | msn.comSilk Road Medical GAAP EPS of -$0.34 beats by $0.04, revenue of $40.07M beats by $2.72MMarch 1, 2023 | finance.yahoo.comQ4 2022 Silk Road Medical Inc Earnings CallFebruary 23, 2023 | seekingalpha.comSILK Silk Road Medical, IncFebruary 21, 2023 | marketwatch.comEmbolic Protection Devices Market Size, Share and Forecast 2028 with Top Countries DataFebruary 7, 2023 | finance.yahoo.comSilk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023January 23, 2023 | finance.yahoo.comWhat Makes Silk Road Medical (SILK) a New Strong Buy StockJanuary 9, 2023 | finance.yahoo.comSilk Road Medical, Inc: Reiterating BUY; raising target to $70December 30, 2022 | finance.yahoo.comSilk Road Medical, Inc (NASDAQ:SILK) Q3 2022 Earnings Call TranscriptDecember 28, 2022 | finance.yahoo.comSilk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 22, 2022 | finance.yahoo.comIs Silk Road Medical (SILK) a Great Stock to Invest in?December 12, 2022 | finance.yahoo.comHere’s What Makes Silk Road Medical (SILK) a Strong StockDecember 5, 2022 | finance.yahoo.comSilk Road Medical (SILK) is a Great Momentum Stock: Should You Buy?December 3, 2022 | seekingalpha.comSilk Road Medical: Revise To Buy As TCAR Procedural Volume Ramps UpNovember 11, 2022 | seekingalpha.comSilk Road Medical, Inc. (SILK) Q3 2022 Earnings Call TranscriptNovember 10, 2022 | finance.yahoo.comSilk Road Medical Third Quarter 2022 Earnings: Beats ExpectationsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SILK Company Calendar Last Earnings2/28/2023Today4/01/2023Next Earnings (Estimated)5/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees352Year FoundedN/APrice Target and Rating Average Stock Price Forecast$53.57 High Stock Price Forecast$70.00 Low Stock Price Forecast$43.00 Forecasted Upside/Downside+35.0%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,010,000.00 Net Margins-39.81% Pretax Margin-39.68% Return on Equity-63.30% Return on Assets-29.92% Debt Debt-to-Equity Ratio0.46 Current Ratio10.41 Quick Ratio9.62 Sales & Book Value Annual Sales$138.64 million Price / Sales10.86 Cash FlowN/A Price / Cash FlowN/A Book Value$4.30 per share Price / Book9.10Miscellaneous Outstanding Shares38,460,000Free Float35,516,000Market Cap$1.50 billion OptionableNot Optionable Beta1.22 Key ExecutivesErica J. RogersPresident, Chief Executive Officer & DirectorLucas W. BuchananChief Financial & Operating OfficerSumaira MacdonaldExecutive Director-MedicalTammy LeitsingerVP-Professional Education & Medical AffairsRobert A. NicholasVice President-Operations & EngineeringKey CompetitorsParagon 28NYSE:FNABeauty HealthNASDAQ:SKINTreace Medical ConceptsNASDAQ:TMCIEmbectaNASDAQ:EMBCAlphatecNASDAQ:ATECView All CompetitorsInsiders & InstitutionsDiametric Capital LPBought 24,132 shares on 3/29/2023Ownership: 0.063%MetLife Investment Management LLCBought 1,848 shares on 3/23/2023Ownership: 0.051%Elizabeth H WeathermanSold 5,000 sharesTotal: $209,550.00 ($41.91/share)Erica J RogersSold 6,000 sharesTotal: $253,380.00 ($42.23/share)Richard RuedySold 2,373 sharesTotal: $113,263.29 ($47.73/share)View All Insider TransactionsView All Institutional Transactions SILK Stock - Frequently Asked Questions Should I buy or sell Silk Road Medical stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares. View SILK analyst ratings or view top-rated stocks. What is Silk Road Medical's stock price forecast for 2023? 5 brokers have issued 12-month price targets for Silk Road Medical's stock. Their SILK share price forecasts range from $43.00 to $70.00. On average, they expect the company's share price to reach $53.57 in the next year. This suggests a possible upside of 36.9% from the stock's current price. View analysts price targets for SILK or view top-rated stocks among Wall Street analysts. How have SILK shares performed in 2023? Silk Road Medical's stock was trading at $52.85 at the beginning of 2023. Since then, SILK stock has decreased by 26.0% and is now trading at $39.13. View the best growth stocks for 2023 here. When is Silk Road Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023. View our SILK earnings forecast. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) issued its earnings results on Tuesday, February, 28th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.03. The business earned $40.07 million during the quarter, compared to the consensus estimate of $37.35 million. Silk Road Medical had a negative trailing twelve-month return on equity of 63.30% and a negative net margin of 39.81%. Silk Road Medical's revenue was up 41.8% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.42) EPS. What ETFs hold Silk Road Medical's stock? ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), American CenturyFocused Dynamic Growth ETF (FDG), First Trust Small Cap Growth AlphaDEX Fund (FYC), Principal Healthcare Innovators ETF (BTEC), Invesco Nasdaq Future Gen 200 ETF (QQQS), Global X Aging Population ETF (AGNG), IQ Chaikin U.S. Small Cap ETF (CSML) and Vanguard Health Care ETF (VHT). What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $176.00 million-$184.00 million, compared to the consensus revenue estimate of $172.70 million. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA). When did Silk Road Medical IPO? (SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. What is Silk Road Medical's stock symbol? Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK." How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Silk Road Medical's stock price today? One share of SILK stock can currently be purchased for approximately $39.13. How much money does Silk Road Medical make? Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.50 billion and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. How many employees does Silk Road Medical have? The company employs 352 workers across the globe. How can I contact Silk Road Medical? Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013. This page (NASDAQ:SILK) was last updated on 4/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.